Remix Therapeutics

Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.

Industries

Biotechnology, Health Care

Headquarters

Cambridge, United States

Stage

Series B

Employees

11-50

Links

Org chart

Peter Smith

Co-Founder, & CEO

Collapse

Zaven Kaprielian

Chief Scientific Officer

Heather Wasserman

COO & Chief Business Officer

Rob Gagnon

CFO

Cecile Blaustein

VP, Program Management

Mark Scruzzarella

SVP, HR

Silvia Buonamici

SVP, in silico & in vivo Biosciences

Kate O'Brien

Senior Director, HR

Matthew Schnaderbeck

Senior Director, CMC

Teams

View all

+13

Board of Directors

16 members

Leadership Team

4 members

CEO and Executive Team

3 members

Founding Team

1 members

Discover similar companies

DoiT International

Santa Clara, United States · Series A

System Soft Technologies

Tampa, United States

Johnson & Johnson

New Brunswick, United States

dbt Labs

Philadelphia, United States · Series D

SupportNinja

Dallas, United States · Private Equity

Mastercard

Harrison, United States · Series E

Wikimedia Foundation

San Francisco, United States

Meta

Menlo Park, United States · IPO

Springboard Collaborative

Philadelphia, United States

Netflix

Los Gatos, United States · Post IPO Debt

Okta

San Francisco, United States · Post IPO Equity

DoorDash

San Francisco, United States · IPO

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.